FDA pharmacologic class
Small Interfering RNA
5 medicines are in FDA's class of small interfering rnas: fitusiran (Qfitlia), givosiran (Givlaari), patisiran (Onpattro), plozasiran (Redemplo) and vutrisiran (Amvuttra). 0 of the 5 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are small interfering rna?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Fitusiran | Qfitlia | none listed | n/a | Yes | No current entry | 0 |
| Givosiran | Givlaari | none listed | n/a | No | No current entry | 0 |
| Patisiran | Onpattro | none listed | n/a | No | No current entry | 0 |
| Plozasiran | Redemplo | none listed | n/a | No | No current entry | 0 |
| Vutrisiran | Amvuttra | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)